MSB 2.51% 97.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-65

  1. 617 Posts.
    lightbulb Created with Sketch. 311
    the assay was the outstanding issue.
    https://hotcopper.com.au/data/attachments/6059/6059822-3a978b13dce78bb6028c2598b1fed6bd.jpg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.